Quick Answer
BIOVIE INC. reported Diluted EPS of $12.12 per share (loss) for fiscal year 2025.
BIOVIE INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$12.12 | +83.4% |
| 2024 | -$73.05 | -372.2% |
| 2023 | -$15.47 | -1359.4% |
| 2022 | -$1.06 | +92.8% |
| 2021 | -$14.82 | -116.4% |
| 2020 | -$6.85 | -599.0% |
| 2019 | -$0.98 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.77 | +83.1% | +21.4% |
| September 30, 2025 | -$0.98 | +86.0% | -553.3% |
| March 31, 2025 | -$0.15 | +92.5% | +96.7% |
| December 31, 2024 | -$4.55 | -106.8% | +35.0% |
| September 30, 2024 | -$7.00 | -139.7% | -250.0% |
| March 31, 2024 | -$2.00 | -365.1% | +9.1% |
| December 31, 2023 | -$2.20 | -340.0% | +24.7% |
| September 30, 2023 | -$2.92 | -668.4% | -579.1% |
- BIOVIE INC. showed an increase of +83.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, BIOVIE INC.’s diluted eps has declined by 1136.7% (from $0.98 per share (loss) to $12.12 per share (loss)).
- The most recent figure is from BIOVIE INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: